< 0 1 0 1 O
1000 1 5 1 5 B-upper_bound
microns 6 13 6 13 I-upper_bound
as 14 16 14 16 O
determined 17 27 17 27 O
by 28 30 28 30 O
angiography 31 42 31 42 O

A 0 1 43 44 O
change 2 8 45 51 O
in 9 11 52 54 O
anti 12 16 55 59 B-treatment
- 16 17 59 60 I-treatment
VEGF 17 21 60 64 I-treatment
agent 22 27 65 70 I-treatment
in 28 30 71 73 O
the 31 34 74 77 O
previous 35 43 78 86 O
two 44 47 87 90 O
administrations 48 63 91 106 O

Active 0 6 107 113 B-chronic_disease
ocular 7 13 114 120 I-chronic_disease
or 14 16 121 123 I-chronic_disease
periocular 17 27 124 134 I-chronic_disease
infection 28 37 135 144 I-chronic_disease
or 38 40 145 147 O
intraocular 41 52 148 159 B-chronic_disease
inflammation 53 65 160 172 I-chronic_disease

Anticipate 0 10 173 183 O
a 11 12 184 185 O
change 13 19 186 192 O
to 20 22 193 195 O
the 23 26 196 199 O
anti 27 31 200 204 B-treatment
- 31 32 204 205 I-treatment
VEGF 32 36 205 209 I-treatment
agent 37 42 210 215 I-treatment
during 43 49 216 222 O
the 50 53 223 226 O
conduct 54 61 227 234 O
of 62 64 235 237 O
the 65 68 238 241 O
study 69 74 242 247 O

BCVA 0 4 248 252 B-clinical_variable
20/63 5 10 253 258 O

Diagnosis 0 9 259 268 O
of 10 12 269 271 O
active 13 19 272 278 B-chronic_disease
CNV 20 23 279 282 I-chronic_disease

Fellow 0 6 283 289 O
eye 7 10 290 293 O
with 11 15 294 298 O
a 16 17 299 300 O
BCVA 18 22 301 305 B-clinical_variable
of 23 25 306 308 O
20/63 26 31 309 314 B-lower_bound
Snellen 32 39 315 322 I-lower_bound
Equivalent 40 50 323 333 I-lower_bound
or 51 53 334 336 O
worse 54 59 337 342 O
, 59 60 342 343 O
with 61 65 344 348 O
advanced 66 74 349 357 O
AMD 75 78 358 361 B-chronic_disease
( 79 80 362 363 O
neovascular 80 91 363 374 B-chronic_disease
or 92 94 375 377 I-chronic_disease
non 95 98 378 381 I-chronic_disease
- 98 99 381 382 I-chronic_disease
exudative 99 108 382 391 I-chronic_disease
AMD 109 112 392 395 I-chronic_disease
with 113 117 396 400 O
foveal 118 124 401 407 O
geographic 125 135 408 418 B-chronic_disease
atrophy 136 143 419 426 I-chronic_disease
) 143 144 426 427 O

Neovascularization 0 18 428 446 B-chronic_disease
other 19 24 447 452 O
than 25 29 453 457 O
due 30 33 458 461 O
to 34 36 462 464 O
AMD 37 40 465 468 B-chronic_disease

Patient 0 7 469 476 O
unsuitable 8 18 477 487 O
for 19 22 488 491 O
IV 23 25 492 494 O
or 26 28 495 497 O
local 29 34 498 503 B-treatment
anesthesia 35 45 504 514 I-treatment

Poor 0 4 515 519 O
or 5 7 520 522 O
non 8 11 523 526 O
- 11 12 526 527 O
responsive 12 22 527 537 O
to 23 25 538 540 O
FDA 26 29 541 544 O
approved 30 38 545 553 O
intravitreal 39 51 554 566 B-treatment
anti 52 56 567 571 I-treatment
- 56 57 571 572 I-treatment
VEGF 57 61 572 576 I-treatment
therapy 62 69 577 584 I-treatment
for 70 73 585 588 O
nAMD 74 78 589 593 B-chronic_disease

Sub 0 3 594 597 B-clinical_variable
- 3 4 597 598 I-clinical_variable
foveal 4 10 598 604 I-clinical_variable
lesion 11 17 605 611 I-clinical_variable
hemorrhage 18 28 612 622 I-clinical_variable
obscuring 29 38 623 632 I-clinical_variable
> 39 40 633 634 O
50 40 42 634 636 B-lower_bound
% 42 43 636 637 I-lower_bound
of 44 46 638 640 O
lesion 47 53 641 647 O

Uncontrolled 0 12 648 660 O
systemic 13 21 661 669 B-chronic_disease
diseases 22 30 670 678 I-chronic_disease
( 31 32 679 680 O
e.g. 32 36 680 684 O
controlled 37 47 685 695 B-chronic_disease
hypertension 48 60 696 708 I-chronic_disease
is 61 63 709 711 O
acceptable 64 74 712 722 O
) 74 75 722 723 O

axial 0 5 724 729 B-clinical_variable
length 6 12 730 736 I-clinical_variable
of 13 15 737 739 O
> 16 17 740 741 O
26.5 17 21 741 745 B-lower_bound
mm 21 23 745 747 I-lower_bound

demonstrated 0 12 748 760 O
myopic 13 19 761 767 B-chronic_disease
degeneration 20 32 768 780 I-chronic_disease

increase 0 8 781 789 O
the 9 12 790 793 O
risk 13 17 794 798 O
of 18 20 799 801 O
structural 21 31 802 812 O
damage 32 38 813 819 O
from 39 43 820 824 O
retrobulbar 44 55 825 836 B-treatment
anesthesia 56 66 837 847 I-treatment
, 66 67 847 848 O
sub 68 71 849 852 B-treatment
- 71 72 852 853 I-treatment
Tenon 72 77 853 858 I-treatment
's 77 79 858 860 I-treatment
anesthesia 80 90 861 871 I-treatment
, 90 91 871 872 O
or 92 94 873 875 O
retrobulbar 95 106 876 887 B-treatment
device 107 113 888 894 I-treatment
positioning 114 125 895 906 I-treatment

other 0 5 907 912 O
co 6 8 913 915 O
- 8 9 915 916 O
morbidities 9 20 916 927 O
that 21 25 928 932 O
in 26 28 933 935 O
the 29 32 936 939 O
investigator 33 45 940 952 O
's 45 47 952 954 O
opinion 48 55 955 962 O
could 56 61 963 968 O
require 62 69 969 976 O
medical 70 77 977 984 O
or 78 80 985 987 O
surgical 81 89 988 996 O
intervention 90 102 997 1009 O
to 103 105 1010 1012 O
prevent 106 113 1013 1020 O
or 114 116 1021 1023 O
treat 117 122 1024 1029 O
visual 123 129 1030 1036 O
loss 130 134 1037 1041 O
or 135 137 1042 1044 O
media 138 143 1045 1050 O
opacity 144 151 1051 1058 O
that 152 156 1059 1063 O
might 157 162 1064 1069 O
result 163 169 1070 1076 O
from 170 174 1077 1081 O
that 175 179 1082 1086 O
condition 180 189 1087 1096 O
( 190 191 1097 1098 O
i.e. 191 195 1098 1102 O
severe 196 202 1103 1109 B-chronic_disease
cataracts 203 212 1110 1119 I-chronic_disease
) 212 213 1119 1120 O

